Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Marinus Pharmaceuticals shares dipped 74.2% to $1.94in pre-market trading.U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.
今天上午美国股票期货走高，道琼斯指数期货周一上涨超过200点。
Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) fell sharply in today's pre-market trading after the company issued an update on the Phase 3 RAISE Trial and reported preliminary first quarter 2024 financial results.
Marinus Pharmicals, Inc.（纳斯达克股票代码：MRNS）的股价在今天的盘前交易中大幅下跌，此前该公司发布了第三阶段RAISE试验的最新情况，并公布了2024年第一季度的初步财务业绩。
Marinus Pharma reported Prelim ZTALMY (Ganaxolone) net product revenue of $7.4 million to $7.6 million for the first quarter.
Marinus Pharma报告称，第一季度Prelim ZTALMY（Ganaxolone）的净产品收入为740万至760万美元。
Marinus Pharmaceuticals shares dipped 74.2% to $1.94in pre-market trading.
Marinus Pharmicals的股价在盘前交易中下跌了74.2％，至1.94美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是一些在今天的盘前交易时段中录得亏损的大型股票。
- Neumora Therapeutics, Inc. (NASDAQ:NMRA) shares declined 17.1% to $11.25 pre-market trading after the FDA placed a clinical hold on the company's Phase 1 NMRA-266 study.
- Roadzen, Inc. (NASDAQ:RDZN) shares fell 14% to $5.04 in pre-market trading.
- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares fell 11.4% to $41.64 in pre-market trading after the company disclosed interim Phase 1/2 data in patients with angelman syndrome after treatment with GTX-102.
- Cogent Biosciences, Inc. (NASDAQ:COGT) shares declined 7.7% to $6.01 in pre-market trading. Cogent Biosciences recently reported preclinical data from CNS-Penetrant ErbB2 Inhibitor Program.
- Polestar Automotive Holding UK PLC (NASDAQ:PSNY) shares fell 7.2% to $1.35 in pre-market trading.
- Molina Healthcare, Inc. (NYSE:MOH) shares fell 7.1% to $350.00 in pre-market trading.
- TORM plc (NASDAQ:TRMD) shares slipped 3.1% to $32.92 in pre-market trading.
- Neumora Therapeutics, Inc.（纳斯达克股票代码：NMRA）股价在盘前交易中下跌17.1％，至11.25美元，此前美国食品药品管理局对该公司的1期 NMRA-266 研究进行了临床搁置。
- 路森公司（纳斯达克股票代码：RDZN）股价在盘前交易中下跌14％，至5.04美元。
- Ultragenyx Pharmaceutical Inc.（纳斯达克股票代码：RARE）股价在盘前交易中下跌11.4％，至41.64美元，此前该公司披露了 GTX-102 治疗后的天使综合征患者的1/2期中期数据。
- Cogent Biosciences, Inc.（纳斯达克股票代码：COGT）股价在盘前交易中下跌7.7％，至6.01美元。Cogent Biosciences最近报告了来自CNS渗透剂eRbB2抑制剂计划的临床前数据。
- 英国极星汽车控股有限公司（纳斯达克股票代码：PSNY）股价在盘前交易中下跌7.2％，至1.35美元。
- 莫利纳医疗保健公司（纽约证券交易所代码：MOH）股价在盘前交易中下跌7.1％，至350.00美元。
- TORM plc（纳斯达克股票代码：TRMD）股价在盘前交易中下跌3.1％，至32.92美元。
Now Read This: Top 3 Tech Stocks That May Explode This Month
现在读这个： 本月可能爆发的三大科技股
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道
